Table 1.
Spike | RBD | N | ≥ 2 Positive antigens | |
---|---|---|---|---|
ROC analysis | ||||
AUC | 0.978 | 0.974 | 0.964 | n/a |
Threshold (cut point) | 0.195 | 0.073 | 0.349 | n/a |
FPR | 0.009 | 0.009 | 0.009 | 0.000 |
TPR | 0.944 | 0.921 | 0.811 | 0.931 |
3 SDs from the mean of the negative controls | ||||
Threshold | 0.190 | 0.186 | 0.396 | n/a |
FPR | 0.011 | 0.000 | 0.007 | 0.000 |
TPR | 0.944 | 0.890 | 0.786 | 0.912 |
Samples used to assess performance a | |||
---|---|---|---|
Sample cohort | Replicates | Number | Total |
Patients with COVID‐19 | 1 | 211 | 392 |
2 | 181 | ||
Pre‐COVID‐19 (negative) | 1 | 300 for N and spike, 296 for RBD | 560 |
2 | 260 for N and RBD, 258 for spike |
Negative samples were excluded from the analysis for spike and RBD if one replicate was positive.